MAMU
Marathon Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.8M | Buy |
122,721
+54,086
| +79% | +$21.9M | 1.6% | 24 |
|
2025
Q1 | $34.2M | Buy |
68,635
+4,042
| +6% | +$2.01M | 1.04% | 36 |
|
2024
Q4 | $33.6M | Sell |
64,593
-2,666
| -4% | -$1.39M | 0.94% | 39 |
|
2024
Q3 | $41.6M | Sell |
67,259
-41,725
| -38% | -$25.8M | 1.15% | 32 |
|
2024
Q2 | $60.3M | Sell |
108,984
-6,391
| -6% | -$3.54M | 1.89% | 15 |
|
2024
Q1 | $67.1M | Sell |
115,375
-4,177
| -3% | -$2.43M | 1.79% | 14 |
|
2023
Q4 | $63.5M | Sell |
119,552
-3,645
| -3% | -$1.94M | 1.78% | 14 |
|
2023
Q3 | $62.4M | Sell |
123,197
-5,652
| -4% | -$2.86M | 1.94% | 15 |
|
2023
Q2 | $67.3M | Sell |
128,849
-13,596
| -10% | -$7.1M | 1.89% | 13 |
|
2023
Q1 | $82.1M | Sell |
142,445
-20,213
| -12% | -$11.7M | 2.3% | 8 |
|
2022
Q4 | $89.6M | Sell |
162,658
-13,553
| -8% | -$7.47M | 2.42% | 4 |
|
2022
Q3 | $89.4M | Sell |
176,211
-167,782
| -49% | -$85.1M | 2.66% | 5 |
|
2022
Q2 | $187M | Sell |
343,993
-20,665
| -6% | -$11.2M | 3.12% | 2 |
|
2022
Q1 | $216M | Sell |
364,658
-29,185
| -7% | -$17.2M | 2.92% | 2 |
|
2021
Q4 | $263M | Buy |
+393,843
| New | +$263M | 3.26% | 2 |
|